These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34518094)

  • 1. Stable prevalence of triazole-resistance in Aspergillus fumigatus complex clinical isolates in a Belgian tertiary care center from 2016 to 2020.
    Resendiz-Sharpe A; Merckx R; Verweij PE; Maertens J; Lagrou K
    J Infect Chemother; 2021 Dec; 27(12):1774-1778. PubMed ID: 34518094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
    Abdolrasouli A; Scourfield A; Rhodes J; Shah A; Elborn JS; Fisher MC; Schelenz S; Armstrong-James D
    Int J Antimicrob Agents; 2018 Nov; 52(5):637-642. PubMed ID: 30103005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait.
    Ahmad S; Khan Z; Hagen F; Meis JF
    Environ Res; 2014 Aug; 133():20-6. PubMed ID: 24906064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
    J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
    Bader O; Weig M; Reichard U; Lugert R; Kuhns M; Christner M; Held J; Peter S; Schumacher U; Buchheidt D; Tintelnot K; Groß U;
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3513-7. PubMed ID: 23669382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
    J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
    Kidd SE; Goeman E; Meis JF; Slavin MA; Verweij PE
    Mycoses; 2015 Jun; 58(6):350-5. PubMed ID: 25885568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan.
    Wang HC; Huang JC; Lin YH; Chen YH; Hsieh MI; Choi PC; Lo HJ; Liu WL; Hsu CS; Shih HI; Wu CJ; Chen YC
    Environ Microbiol; 2018 Jan; 20(1):270-280. PubMed ID: 29124846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triazole resistance in Aspergillus fumigatus isolates in Africa: a systematic review.
    Amona FM; Oladele RO; Resendiz-Sharpe A; Denning DW; Kosmidis C; Lagrou K; Zhong H; Han L
    Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35906879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of the polymorphism of cyp51A sequence and the susceptibility of Aspergillus fumigatus isolates to triazoles determined by commercial gradient test (Etest) and by reference methods.
    Nawrot U; Sulik-Tyszka B; Kurzyk E; Mroczyńska M; Włodarczyk K; Wróblewska M; Basak GW; Brillowska-Dąbrowska A
    Acta Biochim Pol; 2017; 64(4):631-634. PubMed ID: 29202140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triazole Resistance in
    Zhang M; Feng CL; Chen F; He Q; Su X; Shi Y
    Chin Med J (Engl); 2017 Mar; 130(6):665-668. PubMed ID: 28303848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
    Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of triazole-resistant Aspergillus fumigatus sensu stricto in an Argentinean cohort of patients with cystic fibrosis.
    Brito Devoto T; Hermida-Alva K; Posse G; Finquelievich JL; García-Effrón G; Cuestas ML
    Mycoses; 2020 Sep; 63(9):937-941. PubMed ID: 32648614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
    Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year surveillance study of clinical and environmental Triazole-Resistant Aspergillus fumigatus isolates in Iran.
    Khojasteh S; Abastabar M; Haghani I; Valadan R; Ghazanfari S; Abbasi K; Ahangarkani F; Zarrinfar H; Khodavaisy S; Badali H
    Mycoses; 2023 Feb; 66(2):98-105. PubMed ID: 36196507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    Gonzalez-Lara MF; Roman-Montes CM; Diaz-Lomeli P; Rangel-Cordero A; Valenzuela MO; Ponce-de-Leon A; Sifuentes-Osornio J; Ostrosky-Zeichner L; Martinez-Gamboa A
    J Antimicrob Chemother; 2019 Jul; 74(7):2047-2050. PubMed ID: 31220262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France.
    Choukri F; Botterel F; Sitterlé E; Bassinet L; Foulet F; Guillot J; Costa JM; Fauchet N; Dannaoui E
    Med Mycol; 2015 Aug; 53(6):593-6. PubMed ID: 26026171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China.
    Deng S; Zhang L; Ji Y; Verweij PE; Tsui KM; Hagen F; Houbraken J; Meis JF; Abliz P; Wang X; Zhao J; Liao W
    Emerg Microbes Infect; 2017 Dec; 6(12):e109. PubMed ID: 29209054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
    Resendiz-Sharpe A; Mercier T; Lestrade PPA; van der Beek MT; von dem Borne PA; Cornelissen JJ; De Kort E; Rijnders BJA; Schauwvlieghe AFAD; Verweij PE; Maertens J; Lagrou K
    J Antimicrob Chemother; 2019 Sep; 74(9):2759-2766. PubMed ID: 31236587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.